WO1997039128A3 - Use of a modified rev-responsive element (rre) in methods and compositions for combatting hiv infection - Google Patents
Use of a modified rev-responsive element (rre) in methods and compositions for combatting hiv infection Download PDFInfo
- Publication number
- WO1997039128A3 WO1997039128A3 PCT/GB1997/001054 GB9701054W WO9739128A3 WO 1997039128 A3 WO1997039128 A3 WO 1997039128A3 GB 9701054 W GB9701054 W GB 9701054W WO 9739128 A3 WO9739128 A3 WO 9739128A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- rre
- compositions
- methods
- hiv infection
- responsive element
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
- C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- AIDS & HIV (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP53687397A JP2001517074A (en) | 1996-04-15 | 1997-04-15 | Use of the modified REV responsive element (RRE) in methods and compositions for combating HIV infection |
AU25720/97A AU2572097A (en) | 1996-04-15 | 1997-04-15 | Use of a modified REV-responsive element (RRE) in methods and compositions fo r combatting HIV infection |
EP97917335A EP0914443A2 (en) | 1996-04-15 | 1997-04-15 | Use of a modified rev-responsive element (rre) in methods and compositions for combatting hiv infection |
GBGB9802172.8A GB9802172D0 (en) | 1997-04-15 | 1998-02-03 | Labelling arrangement |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9607819.1 | 1996-04-15 | ||
GBGB9607819.1A GB9607819D0 (en) | 1996-04-15 | 1996-04-15 | Anti-hiv agents |
US1726896P | 1996-05-13 | 1996-05-13 | |
US60/017,268 | 1996-05-13 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1997039128A2 WO1997039128A2 (en) | 1997-10-23 |
WO1997039128A3 true WO1997039128A3 (en) | 1998-11-12 |
Family
ID=26309134
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB1997/001054 WO1997039128A2 (en) | 1996-04-15 | 1997-04-15 | Use of a modified rev-responsive element (rre) in methods and compositions for combatting hiv infection |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0914443A2 (en) |
JP (1) | JP2001517074A (en) |
AU (1) | AU2572097A (en) |
CA (1) | CA2252225A1 (en) |
WO (1) | WO1997039128A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000040606A2 (en) * | 1999-01-06 | 2000-07-13 | The Regents Of The University Of California | Modulation of hiv replication using sam68 |
GB0719367D0 (en) * | 2007-10-03 | 2007-11-14 | Procarta Biosystems Ltd | Transcription factor decoys, compositions and methods |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992005195A1 (en) * | 1990-09-20 | 1992-04-02 | Medical Research Council | Viral growth inhibition |
-
1997
- 1997-04-15 EP EP97917335A patent/EP0914443A2/en not_active Withdrawn
- 1997-04-15 CA CA002252225A patent/CA2252225A1/en not_active Abandoned
- 1997-04-15 JP JP53687397A patent/JP2001517074A/en active Pending
- 1997-04-15 AU AU25720/97A patent/AU2572097A/en not_active Abandoned
- 1997-04-15 WO PCT/GB1997/001054 patent/WO1997039128A2/en not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992005195A1 (en) * | 1990-09-20 | 1992-04-02 | Medical Research Council | Viral growth inhibition |
Non-Patent Citations (6)
Also Published As
Publication number | Publication date |
---|---|
WO1997039128A2 (en) | 1997-10-23 |
AU2572097A (en) | 1997-11-07 |
JP2001517074A (en) | 2001-10-02 |
EP0914443A2 (en) | 1999-05-12 |
CA2252225A1 (en) | 1997-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Bodley et al. | Studies on translocation VI: thiostrepton prevents the formation of a ribosome-G factor-guanine nucleotide complex | |
CA2305013A1 (en) | Fusion proteins comprising hiv-1 tat and/or nef proteins | |
CA2136903A1 (en) | Acetic acid derivatives | |
EP0670369A3 (en) | A novel peptide related to human programmed cell death and DNA encoding it | |
EP0590071A4 (en) | Substantially pure receptor like tgf--g(b)1 binding molecules and uses thereof | |
CA2065150A1 (en) | Inhibitors of Thrombin | |
EP1595890A3 (en) | Synthetic peptide inhibitors of HIV transmission | |
CA2172376A1 (en) | Antibodies to cd40 | |
WO2003020756A3 (en) | Hybrid and tandem expression of neisserial proteins | |
EP1310507A3 (en) | Novel peptide nucleic acids | |
EP1666498A3 (en) | Soluble CTLA4 molecules, compositions comprising said molecules and uses thereof | |
EP2270038A3 (en) | GAG binding proteins | |
HUP9802406A2 (en) | Separation and concentration systems based on soluble oligosaccharide binding domains | |
IE890282L (en) | Autonomously replicating sequences in yarrowia lipolytica | |
EP0247730A3 (en) | Antibodies, their preparation and use and products containing them | |
EP1652857A3 (en) | Fusion protein of HIV regulatory/accessory proteins | |
CA2192467A1 (en) | Calcium binding recombinant antibody against protein c | |
CA2093427A1 (en) | Molecular clones of hiv-1 and uses thereof | |
AU3772289A (en) | Endotoxin binding protein and uses thereof | |
WO1997039128A3 (en) | Use of a modified rev-responsive element (rre) in methods and compositions for combatting hiv infection | |
AU3681689A (en) | C-terminus amidation enzyme composition, process for its preparation and its use | |
AU2458988A (en) | The preparation, by genetic manipulation, of anticoagulative protein pp4 | |
WO2000002913B1 (en) | Chemotaxis-inhibiting protein of staphylococcus (chips) and its use | |
CA2273855A1 (en) | Novel feline fc epsilon receptor alpha chain nucleic acid molecules, proteins and uses thereof | |
WO2002055547A3 (en) | Sfrp and peptide motifs that interact with sfrp and methods of their use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG UZ VN AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
ENP | Entry into the national phase |
Ref document number: 2252225 Country of ref document: CA Ref country code: CA Ref document number: 2252225 Kind code of ref document: A Format of ref document f/p: F Ref country code: JP Ref document number: 1997 536873 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1997917335 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 1997917335 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1997917335 Country of ref document: EP |